{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:04:56Z","timestamp":1791669896260,"version":"4.3.4"},"reference-count":30,"publisher":"Bioscientifica","issue":"12","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,28]]},"abstract":"<jats:p>Glucocorticoids (GCs) reduce inflammation and preserve muscle function in boys with Duchenne muscular dystrophy (DMD) but cause pubertal delay. Pubertal induction with testosterone is recommended but longer-term outcome is unknown.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess hypothalamic\u2013pituitary\u2013gonadal axis, muscle volume and function 5 years after pubertal induction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective observational follow-up of a clinical study was conducted. 15 GC-treated males with DMD were treated with incremental testosterone for 2 years (end of regimen +2 years) then evaluated at +2.5 years and +5 years (final follow-up ~3 years after last injection). Data collected included testicular volume (TV), gonadotrophin, testosterone, inhibin B, muscle function, and limb muscle MRI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Participants were 18.7 years (\n                      <jats:sc>s.d.<\/jats:sc>\n                      1.6) at the final follow-up and had been on GC for 11.2 years (\n                      <jats:sc>s.d.<\/jats:sc>\n                      2.2). Testosterone levels were similar at +2.5 years (8.6 nmol\/L (\n                      <jats:sc>s.d.<\/jats:sc>\n                      3.4) and 5 years (11.0 nmol\/L (\n                      <jats:sc>s.d.<\/jats:sc>\n                      6.1). TV increased from 2.8 mL (\n                      <jats:sc>s.d.<\/jats:sc>\n                      0.9) at +2 years to 7.1 mL (\n                      <jats:sc>s.d.<\/jats:sc>\n                      1.8) then 10.6 mL (\n                      <jats:sc>s.d.<\/jats:sc>\n                      3.5) at +2.5 years and +5.0 years (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001). Inhibin B levels increased from 55.6 pg\/mL (\n                      <jats:sc>s.d.<\/jats:sc>\n                      47.0) at baseline to 158.2 pg\/mL (\n                      <jats:sc>s.d.<\/jats:sc>\n                      87.6),\n                      <jats:italic>P<\/jats:italic>\n                      =0.004 at 5 years but remained lower than reference values (mean 305 pg\/mL). Muscle contractile bulk decreased.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>Pubertal induction with testosterone in DMD is associated with HPG axis activation and ongoing increases in inhibin B, TV, and testosterone concentrations. Some patients have normal levels which is promising regarding future fertility. Given the beneficial impact of testosterone on bone health, muscle, and well-being, monitoring testosterone levels in this population and supplementation of sub-optimal levels is important.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-23-0245","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T08:27:43Z","timestamp":1695889663000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":14,"title":["Is ongoing testosterone required after pubertal induction in Duchenne muscular dystrophy?"],"prefix":"10.1530","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-5174","authenticated-orcid":true,"given":"Claire L","family":"Wood","sequence":"first","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK"},{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieren G","family":"Hollingsworth","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edrina","family":"Bokaie","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hughes","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Muni-Lofra","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK"},{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mayhew","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK"},{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod T","family":"Mitchell","sequence":"additional","affiliation":[{"name":"MRC Centre for Reproductive Health, The University of Edinburgh, Queens Medical Research Institute, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Guglieri","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK"},{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"McElvaney","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D","family":"Cheetham","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK"},{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Straub","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK"},{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Nature Reviews. Disease Primers","first-page":"13","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","unstructured":"Duan DGoemans NTakeda SMercuri E & Aartsma-Rus A. Duchenne muscular dystrophy. Nature Reviews. Disease Primers2021713. (https:\/\/doi.org\/10.1038\/s41572-021-00248-3)"},{"key":"bib2","series-title":"Cochrane Database of Systematic Reviews","first-page":"5 CD003725","article-title":"Corticosteroids for the treatment of Duchenne muscular dystrophy","author":"Matthews","year":"2016","unstructured":"Matthews EBrassington RKuntzer TJichi F & Manzur AY. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database of Systematic Reviews20165 CD003725. (https:\/\/doi.org\/10.1002\/14651858.CD003725.pub4)"},{"key":"bib3","series-title":"European Journal of Endocrinology","first-page":"67","article-title":"Pubertal induction in adolescents with DMD is associated with high satisfaction, gonadotropin release and increased muscle contractile surface area","volume":"184","author":"Wood","year":"2021","unstructured":"Wood CLHollingsworth KGHughes EPunniyakodi SMuni-Lofra RMayhew AMitchell RTGuglieri MCheetham TD & Straub V. Pubertal induction in adolescents with DMD is associated with high satisfaction, gonadotropin release and increased muscle contractile surface area. European Journal of Endocrinology202118467\u201379. (https:\/\/doi.org\/10.1530\/EJE-20-0709)"},{"key":"bib4","series-title":"Lancet. Neurology","first-page":"251","article-title":"Diagnosis and management of Duchenne muscular dystrophy, Part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","unstructured":"Birnkrant DJBushby KBann CMApkon SDBlackwell ABrumbaugh DCase LEClemens PRHadjiyannakis SPandya S, et al. Diagnosis and management of Duchenne muscular dystrophy, Part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet. Neurology201817251\u2013267. (https:\/\/doi.org\/10.1016\/S1474-4422(1830024-3)"},{"key":"bib5","series-title":"BMC Pediatrics","first-page":"131","article-title":"Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy","volume":"19","author":"Wood","year":"2019","unstructured":"Wood CLCheetham TDHollingsworth KGGuglieri MAilins-Sahun YPunniyakodi SMayhew A & Straub V. Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy. BMC Pediatrics201919131. (https:\/\/doi.org\/10.1186\/s12887-019-1503-x)"},{"key":"bib6","series-title":"Archives of Disease in Childhood","first-page":"13","article-title":"Variations in the pattern of pubertal changes in boys","volume":"45","author":"Marshall","year":"1970","unstructured":"Marshall WA & Tanner JM. Variations in the pattern of pubertal changes in boys. Archives of Disease in Childhood19704513\u201323. (https:\/\/doi.org\/10.1136\/adc.45.239.13)"},{"key":"bib7","series-title":"Radiographic Atlas of Skeletal Development of the Hand and Wrist","author":"Greulich","year":"1959","unstructured":"Greulich WW & Pyle SIRadiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd ed. Stanford: Stanford University Press1959."},{"key":"bib8","series-title":"Developmental Medicine and Child Neurology","first-page":"633","article-title":"Performance of Upper Limb module for Duchenne muscular dystrophy","volume":"62","author":"Mayhew","year":"2019","unstructured":"Mayhew AGCoratti GMazzone ESKlingels KJames MPane MStraub VGoemans NMercuri ERicotti V, et al. Performance of Upper Limb module for Duchenne muscular dystrophy. Developmental Medicine and Child Neurology2019 62633\u2013639. (https:\/\/doi.org\/10.1111\/dmcn.14361)"},{"key":"bib9","series-title":"Developmental Medicine and Child Neurology","first-page":"1046","article-title":"Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy","volume":"55","author":"Mayhew","year":"2013","unstructured":"Mayhew AGCano SJScott EEagle MBushby KManzur AMuntoni F & North Star Clinical Network for Neuromuscular Disease. Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Developmental Medicine and Child Neurology2013551046\u20131052. (https:\/\/doi.org\/10.1111\/dmcn.12220)"},{"key":"bib10","series-title":"Bone","first-page":"965","article-title":"The relationship between lean body mass and bone mineral content in paediatric health and disease","volume":"35","author":"Crabtree","year":"2004","unstructured":"Crabtree NJKibirige MSFordham JNBanks LMMuntoni FChinn DBoivin CM & Shaw NJ. The relationship between lean body mass and bone mineral content in paediatric health and disease. Bone200435965\u2013972. (https:\/\/doi.org\/10.1016\/j.bone.2004.06.009)"},{"key":"bib11","series-title":"Magnetic Resonance in Medicine","first-page":"1610","article-title":"Investigating the quantitative fidelity of prospectively undersampled chemical shift imaging in muscular dystrophy with compressed sensing and parallel imaging reconstruction","volume":"72","author":"Hollingsworth","year":"2014","unstructured":"Hollingsworth KGHiggins DMMcCallum MWard LCoombs A & Straub V. Investigating the quantitative fidelity of prospectively undersampled chemical shift imaging in muscular dystrophy with compressed sensing and parallel imaging reconstruction. Magnetic Resonance in Medicine2014721610\u20131619. (https:\/\/doi.org\/10.1002\/mrm.25072)"},{"key":"bib12","series-title":"Radiology","first-page":"570","article-title":"Improving highly accelerated fat fraction measurements for clinical trials in muscular dystrophy: origin and quantitative effect of R2* changes","volume":"275","author":"Loughran","year":"2015","unstructured":"Loughran THiggins DMMcCallum MCoombs AStraub V & Hollingsworth KG. Improving highly accelerated fat fraction measurements for clinical trials in muscular dystrophy: origin and quantitative effect of R2* changes. Radiology2015275570\u2013578. (https:\/\/doi.org\/10.1148\/radiol.14141191)"},{"key":"bib13","series-title":"Neuromuscular Disorders","first-page":"390","article-title":"Global T2 versus water T2 in NMR imaging of fatty infiltrated muscles: different methodology, different information and different implications","volume":"24","author":"Carlier","year":"2014","unstructured":"Carlier PG. Global T2 versus water T2 in NMR imaging of fatty infiltrated muscles: different methodology, different information and different implications. Neuromuscular Disorders201424390\u2013392. (https:\/\/doi.org\/10.1016\/j.nmd.2014.02.009)"},{"key":"bib14","series-title":"PLoS One","first-page":"e0162542","article-title":"Upper limb evaluation in Duchenne muscular dystrophy: fat-water quantification by MRI, muscle force and function define endpoints for clinical trials","volume":"11","author":"Ricotti","year":"2016","unstructured":"Ricotti VEvans MRBSinclair CDJButler JWRidout DAHogrel JYEmira AMorrow JMReilly MMHanna MG, et al. Upper limb evaluation in Duchenne muscular dystrophy: fat-water quantification by MRI, muscle force and function define endpoints for clinical trials. PLoS One201611e0162542. (https:\/\/doi.org\/10.1371\/journal.pone.0162542)"},{"key":"bib15","series-title":"PLoS One","first-page":"e0153843","article-title":"A normative model of serum inhibin B in young males","volume":"11","author":"Kelsey","year":"2016","unstructured":"Kelsey TWMiles AMitchell RTAnderson RAHamish WHB & Wallace B. A normative model of serum inhibin B in young males. PLoS One201611e0153843. (https:\/\/doi.org\/10.1371\/journal.pone.0153843)"},{"key":"bib16","series-title":"Endocrinology, Diabetes and Metabolism","first-page":"e00021","article-title":"Paediatric anti-M\u00fcllerian hormone measurement: male and female reference intervals established using the automated Beckman Coulter Access AMH assay","volume":"1","author":"Jopling","year":"2018","unstructured":"Jopling HYates ABurgoyne NHayden KChaloner C & Tetlow L. Paediatric anti-M\u00fcllerian hormone measurement: male and female reference intervals established using the automated Beckman Coulter Access AMH assay. Endocrinology, Diabetes and Metabolism20181e00021. (https:\/\/doi.org\/10.1002\/edm2.21)"},{"key":"bib17","series-title":"Developmental Medicine and Child Neurology","first-page":"633","article-title":"Performance of Upper Limb module for Duchenne muscular dystrophy","volume":"62","author":"Mayhew","year":"2020","unstructured":"Mayhew AGCoratti GMazzone ESKlingels KJames MPane MStraub VGoemans NMercuri E & Pul Working Group. Performance of Upper Limb module for Duchenne muscular dystrophy. Developmental Medicine and Child Neurology202062633\u2013639. (https:\/\/doi.org\/10.1111\/dmcn.14361)"},{"key":"bib18","series-title":"PLoS One","first-page":"e109346","article-title":"A validated age-related normative model for male total testosterone shows increasing variance but no decline after age 40 years","volume":"9","author":"Kelsey","year":"2014","unstructured":"Kelsey TWLi LQMitchell RTWhelan AAnderson RA & Wallace WHB. A validated age-related normative model for male total testosterone shows increasing variance but no decline after age 40 years. PLoS One20149e109346. (https:\/\/doi.org\/10.1371\/journal.pone.0109346)"},{"key":"bib19","series-title":"Archives of Disease in Childhood","first-page":"514","article-title":"Measurement of testicular volume. Its application to assessment of maturation, and its use in diagnosis of hypogonadism","volume":"37","author":"Rundle","year":"1962","unstructured":"Rundle AT & Sylvester PE. Measurement of testicular volume. Its application to assessment of maturation, and its use in diagnosis of hypogonadism. Archives of Disease in Childhood196237514\u2013517. (https:\/\/doi.org\/10.1136\/adc.37.195.514)"},{"key":"bib20","series-title":"Asian Journal of Andrology","first-page":"319","article-title":"Relationship between testicular volume and testicular function: comparison of the Prader orchidometric and ultrasonographic measurements in patients with infertility","volume":"10","author":"Sakamoto","year":"2008","unstructured":"Sakamoto HOgawa Y & Yoshida H. Relationship between testicular volume and testicular function: comparison of the Prader orchidometric and ultrasonographic measurements in patients with infertility. Asian Journal of Andrology200810319\u2013324. (https:\/\/doi.org\/10.1111\/j.1745-7262.2008.00340.x)"},{"key":"bib21","series-title":"BJU International","first-page":"568","article-title":"Redefining abnormal follicle-stimulating hormone in the male infertility population","volume":"110","author":"Gordetsky","year":"2012","unstructured":"Gordetsky JWijngaarden Van E & O\u2019Brien J. Redefining abnormal follicle-stimulating hormone in the male infertility population. BJU International2012110568\u2013572. (https:\/\/doi.org\/10.1111\/j.1464-410X.2011.10783.x)"},{"key":"bib22","series-title":"PLoS One","first-page":"e0181377","article-title":"Follicle stimulating hormone is an accurate predictor of azoospermia in childhood cancer survivors","volume":"12","author":"Kelsey","year":"2017","unstructured":"Kelsey TWMcConville LEdgar ABUngurianu AIMitchell RTAnderson RA & Wallace WHB. Follicle stimulating hormone is an accurate predictor of azoospermia in childhood cancer survivors. PLoS One201712e0181377. (https:\/\/doi.org\/10.1371\/journal.pone.0181377)"},{"key":"bib23","article-title":"Mitch Coles \u2013 \u201cLiving my life the way I want to live it","author":"Action Duchene","year":"2019","unstructured":"Action Duchene. Mitch Coles \u2013 \u201cLiving my life the way I want to live it\u201d. London, UK: Action Duchenne, 2019. (available at: https:\/\/www.actionduchenne.org\/stories\/mitch-coles-living-my-life-the-way-i-want-to-live-it\/)"},{"key":"bib24","article-title":"My lifelong desire","author":"The Guardian","year":"2007","unstructured":"The Guardian. My lifelong desire. London, UK: The Guardian, 2007. (available at: https:\/\/www.theguardian.com\/society\/2007\/jan\/15\/health.socialcare)"},{"issue":"Supplement 3","key":"bib25","series-title":"Translational Andrology and Urology","first-page":"S348","article-title":"Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men","volume":"7","author":"Lee","year":"2018","unstructured":"Lee JA & Ramasamy R. Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men. Translational Andrology and Urology20187(Supplement 3) S348\u2013S352. (https:\/\/doi.org\/10.21037\/tau.2018.04.11)"},{"key":"bib26","series-title":"Bone","first-page":"116248","article-title":"Cessation of ambulation results in a dramatic loss of trabecular bone density in boys with Duchenne muscular dystrophy (DMD)","volume":"154","author":"Crabtree","year":"2022","unstructured":"Crabtree NJRoper H & Shaw NJ. Cessation of ambulation results in a dramatic loss of trabecular bone density in boys with Duchenne muscular dystrophy (DMD). Bone2022154116248. (https:\/\/doi.org\/10.1016\/j.bone.2021.116248)"},{"key":"bib27","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"2386","article-title":"Long-term effect of testosterone therapy on bone mineral density in hypogonadal men","volume":"82","author":"Behre","year":"1997","unstructured":"Behre HMKliesch SLeifke ELink TM & Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. Journal of Clinical Endocrinology and Metabolism1997822386\u20132390. (https:\/\/doi.org\/10.1210\/jcem.82.8.4163)"},{"key":"bib28","series-title":"Journal of Sexual Medicine","first-page":"1504","article-title":"British society for sexual medicine guidelines on adult testosterone deficiency, with statements for UK practice","volume":"14","author":"Hackett","year":"2017","unstructured":"Hackett GKirby MEdwards DJones THWylie KOssei-Gerning NDavid J & Muneer A. British society for sexual medicine guidelines on adult testosterone deficiency, with statements for UK practice. Journal of Sexual Medicine2017141504\u20131523. (https:\/\/doi.org\/10.1016\/j.jsxm.2017.10.067)"},{"key":"bib29","series-title":"NMR in Biomedicine","first-page":"1150","article-title":"Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy","volume":"28","author":"Wary","year":"2015","unstructured":"Wary CAzzabou NGiraudeau CLou\u00ebr Le JMontus MVoit TServais L & Carlier P. Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy. NMR in Biomedicine2015281150\u20131162. (https:\/\/doi.org\/10.1002\/nbm.3352)"},{"key":"bib30","series-title":"Neurology","first-page":"1022","article-title":"Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophy","volume":"86","author":"Hogrel","year":"2016","unstructured":"Hogrel JYWary CMoraux AAzzabou NDecostre VOllivier GCanal ALilien CLedoux IAnnoussamy M, et al. Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophy. Neurology2016861022\u20131030. (https:\/\/doi.org\/10.1212\/WNL.0000000000002464)"}],"container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/12\/12\/EC-23-0245.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/12\/12\/EC-23-0245.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/12\/12\/EC-23-0245.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:46:42Z","timestamp":1784555202000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/ec\/article\/1609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":30,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.1530\/ec-23-0245","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]}}}